Abiopharma

🔍 WELLINGTON SAMANTHA (Executive)

Company: EBAY INC (EBAY)

Report Date: 2026-06-15

Detailed Transactions and Holdings:

• Acquired 1,880 shares of Common Stock (Direct)
  Date: 2026-06-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 15,582.00 | transaction_form_type: 4
• Acquired 1,508 shares of Common Stock (Direct)
  Date: 2026-06-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 17,090.00 | transaction_form_type: 4
• Sold 999 shares of Common Stock at $109.18 per share (Direct)
  Date: 2026-06-15 | Code: F | equity_swap_involved: 0 | shares_owned_after: 16,091.00 | transaction_form_type: 4
• Sold 809 shares of Common Stock at $109.18 per share (Direct)
  Date: 2026-06-15 | Code: F | equity_swap_involved: 0 | shares_owned_after: 15,282.00 | transaction_form_type: 4
• Sold 1,880 shares of Restricted Stock Units -3 (Derivative)
  Date: 2026-06-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 20,680.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
• Sold 1,508 shares of Restricted Stock Units -4 (Derivative)
  Date: 2026-06-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 22,616.00 | transaction_form_type: 4 | Footnotes: F1, F4, F3

Footnotes:

• F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
• F2: The reporting person received restricted stock units, 1/16th of which vests on 6/15/25, and an additional 1/16th of which vests each quarter thereafter. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.
• F3: Not Applicable.
• F4: The reporting person received restricted stock units, 1/16th of which vests on 6/15/26, and an additional 1/16th of which vests each quarter thereafter. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.